![Patrick Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Finn
Präsident bei
TWIST BIOSCIENCE CORPORATION
Vermögen: 18 Mio $ am 31.05.2026
Profil
Patrick J.
Finn is Chairman at Oxford Nanoimaging Ltd. since 2021.
Dr. Finn is President & Chief Operating Officer at Twist Bioscience Corp.
since 2022, with the role starting in 2015.
Former roles include Director-Product Development at Beckman Coulter, Inc. from 2007 to 2010, Director-Business Development at Agilent Technologies, Inc. from 2010 to 2012, Vice President-Sales & Marketing at Universal Display Corp.
from 2012 to 2015, and Vice President-Sales & Marketing at QIAGEN Beverly LLC from 2012 to 2015.
Education includes a doctorate from The University of Southampton and an undergraduate degree from Heriot-Watt University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP. 0,44 % | 21.05.2026 | 274.804 ( 0,44 % ) | 18 Mio $ | 31.05.2026 |
Aktive Positionen von Patrick Finn
| Unternehmen | Position | Beginn |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Präsident | 25.10.2022 |
Oxford Nanoimaging Ltd.
 Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Develops and researches intelligent software and fluorescence microscopy image cells | Vorsitzender | - |
Ehemalige bekannte Positionen von Patrick Finn
| Unternehmen | Position | Ende |
|---|---|---|
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Vertrieb & Marketing | 01.03.2015 |
| UNIVERSAL DISPLAY CORPORATION | Vertrieb & Marketing | 01.03.2015 |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.02.2012 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Corporate Officer/Principal | 01.06.2010 |
Ausbildung von Patrick Finn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Universal Display Corp.
 Universal Display Corp. Electronic Production EquipmentElectronic Technology Engages in research, development and commercialization of organic light emitting diode (OLED), technologies and materials | Electronic Technology |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Health Technology |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Twist Bioscience Corp.
 Twist Bioscience Corp. BiotechnologyHealth Technology Manufactures, distributes and sells synthetic DNA products through online | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
 Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Nanoimaging Ltd.
Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Develops and researches intelligent software and fluorescence microscopy image cells | Technology Services |
